Profil
Mukul Agarwal is currently the Vice President of Corporate Development at Forty Seven, Inc. Prior to this, he worked as the Senior Director of Corporate Development and Strategy at Anacor Pharmaceuticals LLC.
From 2016 to 2019, he was the Vice President of Business Development at Revance Therapeutics, Inc. Mr. Agarwal holds a Master's in Business Administration from Carnegie Mellon University, a graduate degree from The Ohio State University, and an undergraduate degree from the Indian Institute of Technology New Delhi.
Postes actifs de Mukul Agarwal
| Sociétés | Poste | Début |
|---|---|---|
| FORTY SEVEN, INC. | Corporate Officer/Principal | - |
Anciens postes connus de Mukul Agarwal
| Sociétés | Poste | Fin |
|---|---|---|
| REVANCE THERAPEUTICS, INC. | Corporate Officer/Principal | 01/03/2019 |
| ANACOR PHARMACEUTICALS INC | Corporate Officer/Principal | - |
Formation de Mukul Agarwal
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Carnegie Mellon University
Carnegie Mellon University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Revance Therapeutics, Inc.
Revance Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for esthetics, skincare and therapeutics | Health Technology |
The Ohio State University
The Ohio State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Indian Institute of Technology New Delhi
Indian Institute of Technology New Delhi Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Anacor Pharmaceuticals LLC
Anacor Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a bio pharmaceutical company | Health Technology |
Forty Seven, Inc.
Forty Seven, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for cancer treatment | Health Technology |
















